The aim of this study was to develop a novel therapeutic method for improving immune system regulation in SLE using escalating dose self-antigen dsDNA immunotherapy. Female Balb/c mice were given a single intraperitoneal injection of 0.5 ml pristane. Starting at 12 weeks after injection, the mice were evaluated for clinical and serological manifestations. Mice with lupus signs (PIL mice) were divided into two groups; a positive control group and PIL (0.1 µg/ml, 1 µg/ml, 10 µg/ml) EDI dsDNA group. EDI dsDNA was administered once every week in consecutively. The doses would increase every week. dsDNA was complexed with the cationic polyethyleneimine (PEI) before injection. Samples were analyzed for autoantibodies levels (dsDNA, ANA) and TGF-β cytokine from serum using ELISA and T-Reg, mature dendritic cells from spleen using flowcytometry. Liver and kidney function was measured by ALT/AST, Ur/Cr, Proteinuria and ALP serum. Efficacy study result showed that immune profile, inflammation marker, proteinuria, liver and renal functions were improved. significantly decreased ANA (p=0.02), anti-dsDNA (p=0.03), dendritic cell mature (p=0.02) compare to positive control, and not significantly decreases Th17 cells (p=0,18) but the result tend to get lower. Desensitization using self-antigen dsDNA was increased T-reg proliferation (p=0.00) and level of TGF-β (p=0.03) significantly compare to positive control. Analysis for side effect revealed that PIL with EDI dsDNA decrease SGOT(p=0.87) SGPT (p=0.22), Ureum (p=0.009), Creatinin (p=0,87), Proteinuria (p=0.009) and ALP (p=0,65) compared to positive control. Desensitization using self-antigen dsDNA coupled to PEI was able to modulate T-Reg as a regulator immune respon and inhibit B and T cell functions and potential to be developed further as new, safe and effective immunotherapy against pristane-induced SLE BALB/c mice.

1.
Zhu
,
Jiankun
,
Mohan
,
Chandra
.
2007
. SLE 1, 2, 3 Genetic Disection of Lupus. In:
Immune Mediated Disease – From Theory to Therapy
.
Springer
:
New York
2.
Sawla
P.
,
Hossain
,
A.
,
Hahn
,
B.H.
,
Singh
,
R.P.
2012
.
Regulatory T cells in systemic lupus erythematosus (SLE): role of peptide tolerance
.
Autoimmun. Rev.
11
,
611
614
3.
PUSDATIN
.
2017
.
Situasi Lupus di Indonesia
.
KEMENKES RI.
ISSN:
4.
Choi
,
Jinyoung.
,
Sang Taek
Kim
, and
Joe
Craft
.
2012
.
The pathogenesis of systemic lupus erythematosus-an Update
.
Current Opinion of Immunology
24
(
6
):
651
657
.
5.
Pathak
,
S.
, &
Mohan
,
C.
2011
.
Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models
.
Arthritis research & therapy
,
13
(
5
),
241
6.
Wichainun
,
R.
,
Kasitanon
,
N.
,
Wangkaew
,
S.
,
Hongsongkiat
,
S.
,
Sukitawut
,
W.
, &
Louthrenoo
,
W.
2013
.
Sensitivity and specificity of ANA and anti-dsDNA in the diagnosis of systemic lupus erythematosus: a comparison using control sera obtained from healthy individuals and patients with multiple medical problems
.
Asian Pacific journal of allergy and immunology
,
31
(
4
),
292
.
7.
Kusworini
,
Handono
K
,
Dona
M
,
Kalim
H.
Association between the low levels of vitamin D and treg function in systemic lupus erythematosus patients
.
Acta Med Indones-Indones J Intern Med.
2015
;
45
(
1
):
26
31
8.
Larche
,
M.
&
Wraith
,
D. C.
2005
.
Peptide-based therapeutic vaccines for allergic and autoimmune diseases
.
Nat. Med.
11
,
S69
S76
9.
Tarzi
,
M.
,
Klunker
S
,
Texier
C
,
Verhoef
A
,
Stapel
SO
,
Akdis
CA
,
Maillere
B
,
Kay
AB
,
Larché
M.
2006
.
Induction of interleukin-10 and suppressor of cytokine signalling-3 gene expression following peptide immunotherapy
.
Clin. Exp. Allergy
36
,
465
474
10.
Campbell
,
J. D.
,
Buckland
KF
,
McMillan
SJ
,
Kearley
J
,
Oldfield
WL
,
Stern
LJ
, et al. 
2009
.
Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression
.
J. Exp. Med.
206
,
1535
1547
11.
Fousteri
,
G.
,
Dave
A
,
Bot
A
,
Juntti
T
,
Omid
S
,
von Herrath
M.
2010
.
Subcutaneous insulin B:9-23/IFA immunisation induces Tregs that control late-stage prediabetes in NOD mice through IL-10 and IFNgamma
.
Diabetologia
53
,
1958
1970
12.
Anderson
,
P. O.
,
Barbara
A.
Manzo
,
Anette
Sundstedt
,
Sophie
Minaee
,
Alistair
Symonds
,
Sabah
Khalid
, et al. 
2006
.
Persistent antigenic stimulation alters the transcription program in T cells, resulting in antigen-specific tolerance
.
Eur. J. Immunol.
36
,
1374
1385
13.
Gabrysova
,
L.
,
Nicolson
KS
,
Streeter
HB
,
Verhagen
J
,
Sabatos-Peyton
CA
,
Morgan
DJ
,
Wraith
DC
.
2009
.
Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells
.
J. Exp. Med.
206
,
1755
1767
This content is only available via PDF.
You do not currently have access to this content.